AGE

AgeX Therapeutics, Inc. (AGE) | Rumor.io

AgeX Therapeutics

AGE

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)98%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about AGE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% +0	0% 0

Mar 15

$AGE AgeX Therapeutics, Inc. trading was halted multiple times on March 15, 2024, due to volatility.
The company announced a proposed merger with Serina on March 2, 2024.
AgeX Therapeutics, Inc. management changes and annual general meeting results were announced on March 15, 2024.

Generated by AI

Sentiment

Of the messages about AGE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +0.8	85.75% +11.71
Bearish	—	—	0% -0.8	14.25% -11.71

Oct 8

$AGE has seen significant price increases, with some traders reporting gains of over $1200 in a single day.
The company's news and developments, such as the acquisition by Juvenescence, have contributed to its recent success and potential for further growth.
Traders are optimistic about $AGE's future, with some predicting it will reach prices of $6 or more, and others reporting that it has the potential to be a "big gainer".

Generated by AI

Topics

Of the messages about AGE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	0%	0%	0%
Announcements	—	100%	13.91%	48.92%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0%
Macro	—	0%	86.09%	40.78%
Technical Analysis	—	0%	0%	10.31%

Community

Of the messages about AGE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	15.31%	49.64%
Newcomers	0%	0%	84.69%	50.36%

Regulars· Mar 15

AgeX Therapeutics, Inc. (AGE) stock was halted for the third time today, with trading resumed at 10:22:28 ET.
The company's management made significant changes, and announced the results of its annual general meeting, with trading resumed multiple times throughout the day.
AgeX Therapeutics, Inc. (AGE) stock was halted twice today, with trading resumed multiple times, and was also featured in a "US Companies Moving the Markets" evening edition update.

Newcomers· Nov 17

Newcomers are focused on the significant price drop of AgeX Therapeutics, Inc. ($AGE) following a deal announcement with Pfizer ($PFE).
The newcomers are discussing the license agreement between Serina Therapeutics (a subsidiary of AgeX Therapeutics) and Pfizer, which they see as a major development for the company.
Some newcomers are buying into the stock, with one investor adding a bit into the open and another planning to buy in after a merger announcement with Serina Therapeutics.

Generated by AI

Also Discussed

Investors talking about AGE also mention

#	Name	Attention
1	Lotus Technology Inc. ADRLOT	0%0
2	BlackRock Enhanced Global Dividend TrustBOE	0%0
3	Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETFPDN	0.02%new
4	WisdomTree Target Range FundGTR	0%new
5	Ameren CorporationAEE	0%new
6	Penumbra Inc.PEN	0%new
7	VanEck Steel ETFSLX	0%-0.01
8	THR - Thermon Group Holdings, Inc.	——
9	BlackRock 2037 Municipal Target Term TrustBMN	0%new
10	Valaris Ltd.VAL	0%new